USD 3.12
(-11.36%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 75.83 Million USD | 26.46% |
2022 | 59.97 Million USD | 65.47% |
2021 | 36.24 Million USD | 40.45% |
2020 | 25.8 Million USD | 173.33% |
2019 | 9.44 Million USD | -12.31% |
2018 | 10.76 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 73.27 Million USD | -6.63% |
2024 Q1 | 78.47 Million USD | 3.48% |
2024 Q2 | 78.47 Million USD | 0.01% |
2023 Q2 | 86.82 Million USD | 25.1% |
2023 FY | 75.83 Million USD | 26.46% |
2023 Q1 | 69.4 Million USD | 15.74% |
2023 Q4 | 75.83 Million USD | -19.34% |
2023 Q3 | 94.01 Million USD | 8.28% |
2022 Q2 | 65.58 Million USD | 35.64% |
2022 Q1 | 48.35 Million USD | 33.42% |
2022 FY | 59.97 Million USD | 65.47% |
2022 Q4 | 59.97 Million USD | 4.0% |
2022 Q3 | 57.66 Million USD | -12.08% |
2021 FY | 36.24 Million USD | 40.45% |
2021 Q1 | 36.12 Million USD | 40.0% |
2021 Q4 | 36.24 Million USD | 52.15% |
2021 Q3 | 23.82 Million USD | -49.26% |
2021 Q2 | 46.94 Million USD | 29.95% |
2020 FY | 25.8 Million USD | 173.33% |
2020 Q4 | 25.8 Million USD | 72.7% |
2020 Q3 | 14.94 Million USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2019 Q4 | 9.44 Million USD | 0.0% |
2019 FY | 9.44 Million USD | -12.31% |
2018 FY | 10.76 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 98.846% |
Allurion Technologies Inc. | 6.17 Million USD | -1128.926% |
Artivion, Inc. | 81.97 Million USD | 7.489% |
Avanos Medical, Inc. | 163.2 Million USD | 53.531% |
Butterfly Network, Inc. | 75.83 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | 90.284% |
Boston Scientific Corporation | 2.48 Billion USD | 96.947% |
Perspective Therapeutics, Inc. | 1.4 Million USD | -5282.328% |
CONMED Corporation | 318.32 Million USD | 76.176% |
Edwards Lifesciences Corporation | 1.16 Billion USD | 93.508% |
Paragon 28, Inc. | 98.06 Million USD | 22.664% |
Glaukos Corporation | 41.98 Million USD | -80.624% |
Globus Medical, Inc. | 848.13 Million USD | 91.058% |
Inspire Medical Systems, Inc. | 33.88 Million USD | -123.807% |
Integer Holdings Corporation | 239.71 Million USD | 68.364% |
Medtronic plc | 5.21 Billion USD | 98.546% |
Nevro Corp. | 118.67 Million USD | 36.097% |
Owlet, Inc. | 6.49 Million USD | -1067.981% |
Penumbra, Inc. | 388.02 Million USD | 80.456% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.39 Billion USD | 96.834% |
Sonendo, Inc. | 11.07 Million USD | -584.82% |
STERIS plc | 674.53 Million USD | 88.757% |
Stryker Corporation | 4.84 Billion USD | 98.434% |
Vapotherm, Inc. | 22.96 Million USD | -230.185% |
Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 96.821% |